- Previous Close
0.390 - Open
0.390 - Bid 0.390 x --
- Ask 0.410 x --
- Day's Range
0.390 - 0.420 - 52 Week Range
0.120 - 0.485 - Volume
513,480 - Avg. Volume
750,818 - Market Cap (intraday)
213.147M - Beta (5Y Monthly) 1.26
- PE Ratio (TTM)
-- - EPS (TTM)
-0.000 - Earnings Date Mar 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Zhong Ji Longevity Science Group Limited, an investment holding company, engages in the money lending business in Hong Kong and Mainland China. It operates through Longevity Science Business; Money Lending and Financial Advisory Business; Securities and Other Investments; and Property Investment Segments. The company is involved in the provision of diagnostic consultation, and health and medical testing and checking services, as well as distribution of healthcare cancer prevention and immunity supplements. It also engages in the holding of equity investments; investment in short and long-term financial assets; provision of financial and investment consulting activities; and investment in properties. In addition, the company offers health consulting services; and trades in medical products. Zhong Ji Longevity Science Group Limited was incorporated in 1994 and is based in Kowloon Bay, Hong Kong.
55
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 0767.HK
View MorePerformance Overview: 0767.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0767.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0767.HK
View MoreValuation Measures
Market Cap
213.15M
Enterprise Value
151.36M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.82
Price/Book (mrq)
0.52
Enterprise Value/Revenue
1.95
Enterprise Value/EBITDA
130.04
Financial Highlights
Profitability and Income Statement
Profit Margin
-20.59%
Return on Assets (ttm)
-6.73%
Return on Equity (ttm)
-8.38%
Revenue (ttm)
168.63M
Net Income Avi to Common (ttm)
-34.73M
Diluted EPS (ttm)
-0.000
Balance Sheet and Cash Flow
Total Cash (mrq)
47.84M
Total Debt/Equity (mrq)
4.78%
Levered Free Cash Flow (ttm)
--